Literature DB >> 27315777

Prominent Lymphatic Vessel Hyperplasia with Progressive Dysfunction and Distinct Immune Cell Infiltration in Lymphedema.

Epameinondas Gousopoulos1, Steven T Proulx1, Jeannette Scholl1, Maja Uecker1, Michael Detmar2.   

Abstract

Lymphedema is a common complication that occurs after breast cancer treatment in up to 30% of the patients undergoing surgical lymph node excision. It is associated with tissue swelling, fibrosis, increased risk of infection, and impaired wound healing. Despite the pronounced clinical manifestations of the disease, little is known about the morphological and functional characteristics of the lymphatic vasculature during the course of lymphedema progression. We used an experimental murine tail lymphedema model where sustained fluid stasis was generated on disruption of lymphatic flow, resulting in chronic edema formation with fibrosis and adipose tissue deposition. Morphological analysis of the lymphatic vessels revealed a dramatic expansion during the course of the disease, with active proliferation of lymphatic endothelial cells at the early stages of lymphedema. The lymphatic capillaries exhibited progressively impaired tracer filling and retrograde flow near the surgery site, whereas the collecting lymphatic vessels showed a gradually decreasing contraction amplitude with unchanged contraction frequency, leading to lymphatic contraction arrest at the later stages of the disease. Lymphedema onset was associated with pronounced infiltration by immune cells, predominantly Ly6G(+) and CD4(+) cells, which have been linked to impaired lymphatic vessel function.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27315777     DOI: 10.1016/j.ajpath.2016.04.006

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

1.  T helper 2 differentiation is necessary for development of lymphedema.

Authors:  Catherine L Ly; Gabriela D García Nores; Raghu P Kataru; Babak J Mehrara
Journal:  Transl Res       Date:  2018-12-21       Impact factor: 7.012

2.  Regulatory T cell transfer ameliorates lymphedema and promotes lymphatic vessel function.

Authors:  Epameinondas Gousopoulos; Steven T Proulx; Samia B Bachmann; Jeannette Scholl; Dimitris Dionyssiou; Efterpi Demiri; Cornelia Halin; Lothar C Dieterich; Michael Detmar
Journal:  JCI Insight       Date:  2016-10-06

3.  Mouse tail models of secondary lymphedema: fibrosis gradually worsens and is irreversible.

Authors:  Chenxiao Zhou; Wanchun Su; Haotian Han; Na Li; Gang Ma; Lei Cui
Journal:  Int J Clin Exp Pathol       Date:  2020-01-01

Review 4.  Lymphatic Vessel Network Structure and Physiology.

Authors:  Jerome W Breslin; Ying Yang; Joshua P Scallan; Richard S Sweat; Shaquria P Adderley; Walter L Murfee
Journal:  Compr Physiol       Date:  2018-12-13       Impact factor: 9.090

Review 5.  Current Understanding of Pathological Mechanisms of Lymphedema.

Authors:  Cynthia Sung; Sarah Wang; Jerry Hsu; Roy Yu; Alex K Wong
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-11-25       Impact factor: 4.947

6.  Extracellular vesicle-associated VEGF-C promotes lymphangiogenesis and immune cells infiltration in endometriosis.

Authors:  Wan-Ning Li; Kuei-Yang Hsiao; Chu-An Wang; Ning Chang; Pei-Ling Hsu; Chung-Hsien Sun; Shang-Rung Wu; Meng-Hsing Wu; Shaw-Jenq Tsai
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-01       Impact factor: 11.205

Review 7.  New and Emerging Treatments for Lymphedema.

Authors:  Mark V Schaverien; Melissa B Aldrich
Journal:  Semin Plast Surg       Date:  2018-04-09       Impact factor: 2.314

8.  The Kinetics of Lymphatic Dysfunction and Leukocyte Expansion in the Draining Lymph Node during LTB4 Antagonism in a Mouse Model of Lymphedema.

Authors:  Matthew T Cribb; Lauren F Sestito; Stanley G Rockson; Mark R Nicolls; Susan N Thomas; J Brandon Dixon
Journal:  Int J Mol Sci       Date:  2021-04-24       Impact factor: 6.208

9.  Review article: Novel technologies in the treatment and monitoring of advanced and relapsed epithelial ovarian cancer.

Authors:  Paula Cunnea; Sally Gowers; James E Moore; Emmanuel Drakakis; Martyn Boutelle; Christina Fotopoulou
Journal:  Converg Sci Phys Oncol       Date:  2017-02-23

Review 10.  Current Advancements in Animal Models of Postsurgical Lymphedema: A Systematic Review.

Authors:  Jerry F Hsu; Roy P Yu; Eloise W Stanton; Jin Wang; Alex K Wong
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-08-27       Impact factor: 4.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.